IL6 and hepatocellular carcinoma: OA, on the other hand, has been reported to significantly inhibit IL-6 levels in insulin-resistant human hepatoma (HepG2) cells [50] and inhibit the secretion of IL-6 from differentiating 3T3-L1 adipocytes [51].